Journal article
Treatment regimens for optimising outcomes in patients with neovascular age-related macular degeneration
Abstract
Practice patterns for neovascular age-related macular degeneration (nAMD) have evolved from the landmark registration trials of vascular endothelial growth factor (VEGF) inhibitors. Non-monthly regimens like treat-and-extend (T&E) have become popular due to their effectiveness in clinical practice. T&E regimens attempt to limit the burden of visits and treatments by allowing progressively longer treatment intervals, but in so doing, are …
Authors
Teo KYC; Eldem B; Joussen A; Koh A; Korobelnik J-F; Li X; Loewenstein A; Lövestam-Adrian M; Navarro R; Okada AA
Journal
Eye, Vol. 39, No. 5, pp. 860–869
Publisher
Springer Nature
Publication Date
4 2025
DOI
10.1038/s41433-024-03370-0
ISSN
0950-222X